| Announce Date | 02/03/2026 |
| EPS Normalized Actual | $0.93 (Beat by $0.04) |
| EPS GAAP Actual | $0.93 (Beat by $0.04) |
| Revenue Actual | $1.1771B |
| Revenue Surprise | Beat by $1177.1M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 5.7 | 24.54 | 5.55965 | 5.8337 | 4 |
| Dec 2029 | 5.75 | 24.32 | 5.5467 | 5.92035 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 0.71 | 0.71 | 1.1771B | 0.37% | 1177.1M |
| FQ3 2025 (Sep 2025) | 0.8 | 0.8 | 1.1255B | -66.82% | 1125.5M |
| FQ2 2025 (Jun 2025) | 0.72 | 0.72 | 1.1404B | -72.15% | 1140.4M |
| FQ1 2025 (Mar 2025) | 0.68 | 0.68 | 1.1444B | 8.87% | 1144.4M |
| FQ4 2024 (Dec 2024) | 0.97 | 0.97 | 1.1727B | -63.92% | 1172.7M |
| FQ3 2024 (Sep 2024) | 0.66 | 0.66 | 1.8776B | 1.12% | 1877.6M |
| FQ2 2024 (Jun 2024) | 0.66 | 0.66 | 1.9632B | 46.72% | 1963.2M |
| FQ1 2024 (Mar 2024) | 0.52 | 0.52 | 1.0429B | 0.46% | 1042.9M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 1.81826 | -- | 1.772 | 1.86878 | 3 |
| FQ3 2028 (Sep 2028) | 1.59717 | -- | 1.55653 | 1.64155 | 3 |
| FQ2 2028 (Jun 2028) | 1.44688 | -- | 1.41007 | 1.48708 | 3 |
| FQ1 2028 (Mar 2028) | 1.29625 | -- | 1.26327 | 1.33227 | 3 |
| FQ4 2027 (Dec 2027) | 1.27456 | -- | 1.23301 | 1.32672 | 1 |
| FQ3 2027 (Sep 2027) | 1.05936 | -- | 1.022 | 1.09479 | 2 |
| FQ2 2027 (Jun 2027) | 0.92003 | -- | 0.88758 | 0.9508 | 2 |
| FQ1 2027 (Mar 2027) | 0.82874 | -- | 0.79951 | 0.85645 | 2 |
| FQ4 2026 (Dec 2026) | 1.10093 | 35.51 | 1.05601 | 1.15032 | 2 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 1.56B | -- | 1.53B | 1.6B | 2 |
| FQ3 2028 (Sep 2028) | 1.5B | -- | 1.47B | 1.53B | 2 |
| FQ2 2028 (Jun 2028) | 1.43B | -- | 1.4B | 1.46B | 2 |
| FQ1 2028 (Mar 2028) | 1.36B | -- | 1.33B | 1.39B | 2 |
| FQ4 2027 (Dec 2027) | 1.44B | -- | 1.4B | 1.48B | 1 |
| FQ3 2027 (Sep 2027) | 1.32B | -- | 1.29B | 1.36B | 3 |
| FQ2 2027 (Jun 2027) | 1.28B | -- | 1.24B | 1.31B | 3 |
| FQ1 2027 (Mar 2027) | 1.23B | -- | 1.2B | 1.26B | 3 |
| FQ4 2026 (Dec 2026) | 1.31B | 10.39 | 1.27B | 1.36B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 0.71 | 0.71 | 100% | |
| FQ3 2025 (Sep 2025) | 0.8 | 0.8 | 100% | |
| FQ2 2025 (Jun 2025) | 0.72 | 0.72 | 100% | |
| FQ1 2025 (Mar 2025) | 0.68 | 0.68 | 100% | |
| FQ4 2024 (Dec 2024) | 0.97 | 0.97 | 100% | |
| FQ3 2024 (Sep 2024) | 0.66 | 0.66 | 100% | |
| FQ2 2024 (Jun 2024) | 0.66 | 0.66 | 100% | |
| FQ1 2024 (Mar 2024) | 0.52 | 0.52 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $0B | $1.18B | $1177.1M | 100% |
| FQ3 2025 (Sep 2025) | $0B | $1.13B | $1125.5M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $1.14B | $1140.4M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $1.14B | $1144.4M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.17B | $1172.7M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.88B | $1877.6M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.96B | $1963.2M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.04B | $1042.9M | 100% |